Uterine polyps, or endometrial polyps, are localized overgrowths of the endometrial lining inside the uterus. Despite being usually benign, the polyps may lead to symptoms such as abnormal menstrual bleeding, spotting intermenstrual, and infertility.
Management is based on several variables, including the patient's age, reproductive intention, severity of symptoms, and risk of malignancy. Effective treatment modalities vary from conservative management to surgical resection, with hysteroscopic removal as the current gold standard.
Let’s discuss some of the most evidence-based methods of diagnosis and treatment for uterine polyps, including indications for non-surgical therapy and how health insurance can facilitate access to such care.
Diagnosis of Uterine Polyps requires a combination of clinical evaluation and imaging modalities:
For the majority of cases, the first imaging method, TVS, can detect intrauterine lesions as isoechoic or hyperechoic masses. Color Doppler may reveal a central feeding vessel, a hallmark feature of endometrial polyps.
This procedure enhances visualization by providing sterile saline into the uterine cavity that outlines the endometrial layers. It enhances sensitivity for the detection of small or sessile polyps, which are not visualized on routine ultrasound.
Considered the definitive diagnostic tool, hysteroscopy allows direct inspection of the uterine cavity. It also enables immediate polyp removal during the same procedure, making it both diagnostic and therapeutic.
It is helpful in determining hyperplasia or malignancy in high-risk individuals. However, due to the focal nature of polyps, biopsy may miss the lesion unless image-guided sampling is employed.
These modalities combined enable clinicians to ascertain the presence, size, vascularity, and pathologic potential of uterine polyps for appropriate planning of therapy.
Yes, some small uterine polyps can disappear on their own or be treated conservatively without emergency surgery, particularly if they are small, not symptomatic, and found incidentally on imaging.
Premenopausal women with small polyps (<1.5 cm) and no troublesome symptoms can be treated with observation only. Follow-up with a transvaginal ultrasound or hysterosonography every few months ensures that the polyps are not enlarging or causing endometrial changes.
Short-term treatment with the following hormonal drugs occasionally controls the bleeding and decreases polyps:
However, these are symptomatic therapies and do not remove the polyp tissue. Recurrence after cessation of the drug is common. Non-surgical interventions are therefore adjunctive or temporizing.
Surgical removal of polyps in the uterus is indicated in certain clinical situations in which treatment with conservative approaches will be unsafe or ineffective. The following signs of surgery are:
These indications enable gynecologists to choose patients most likely to benefit from definitive surgical treatment, e.g., hysteroscopic polypectomy.
If hysteroscopy is unavailable or not possible, alternatives are:
Seldom indicated, hysterectomy is reserved for:
It is a significant surgical procedure with long-term implications and is not the first-line therapy for benign polyps.
Even though most of the uterine polyps are benign, some minority can have precancerous or malignant changes, particularly in:
In such high-risk cases, histopathological examination is essential after removal. EIN or endometrial adenocarcinoma can be present in <5% of cases.
Yes, uterine polyps have been found to affect fertility in several ways:
Clinical experience confirms that the elimination of polyps via hysteroscopic polypectomy can significantly enhance pregnancy outcomes, particularly in patients receiving assisted reproductive therapies like intrauterine insemination (IUI) or in vitro fertilization (IVF).
Yes, uterine polyps do recur even after removal, especially in some high-risk women. Recurrence is more likely in:
To decrease the risk of recurrence, most clinicians advocate for repeated periodic imaging, measures for control of hormones, and, for some patients, treatment with progestin following the procedure. Treatment of underlying metabolic or endocrine disease is most critical in long-term treatment and enhanced reproductive outcomes.
Most patients experience a quick and uncomplicated recovery following hysteroscopic polypectomy, as the procedure involves minimal tissue disruption. Most patients have:
Follow-up is necessary and can involve:
In addition, such patients with underlying disturbances of hormones can be referred to an endocrinologist to manage long-term risk factors.
Uterine polyps are a common gynecological condition that may lead to abnormal bleeding, infertility, and, in advanced cases, malignancy. Observation or hormonal management is adequate for some, but hysteroscopic excision is the optimal and most effective treatment.
Effective diagnosis through hysteroscopy and ultrasound with subsequent selective excision results in relief of symptoms along with restoration of reproductive function.
Also Read:
→ What Can I Eat to Get Rid of Tonsil Stones
→ How Do You Treat Cortical Atrophy
→ What is Health Insurance for Infertility Treatments
→ What are the Health Insurance Policies for Glaucoma Treatments